onconxt igics 2020 agenda 28 & 29

2020INDIANGASTROINTESTINALCANCERS SYMPOSIUM

7TH-8TH & 28TH-29TH AUGUST

Organised by

Virtual Meeting Managed by

SCIENTIFIC PROGRAM

https://www.onconxt.com/igics/registration


INDIAN GASTROINTESTINALCANCERS SYMPOSIUM 20207TH-8TH & 28TH-29TH AUGUST, 2020

Dear Colleagues,The Indian Gastrointestinal Cancers Symposium 2020 was conceived with an idea to form our national review meet to discuss noteworthy publications and practice-changing trends. Hence the theme of this academia is “Understanding, Integrating & Accelerating Personalized Care” for patients across multiple types of gastrointestinal cancers. This meeting will be held in two batches on 7th and 8th August and 28th and 29th August as an educational virtual series.This symposium will be an annual feature amongst multiple educational programs organised by OncoNXT – a collaborative educational initiative for oncology and haematology.The primary goal of this meeting is to guide practising oncologist on integrating the best and most current evidence into their day-to-day routine care for patients with GI cancers. This symposium series will also bring a practical perspective on how to optimize multidisciplinary care for some of the more complex clinical management decisions. Presenters from across India will be invited, and International Speakers will discuss how biomarker testing, age, and other patients and disease-related factors can influence appropriate diagnostic and treatment approaches.Presentations, debates, a case-based grand round will be organized around specific disease states, including oesophagal and gastric cancers; pancreatic and hepatobiliary cancers; and colorectal and anal cancers. However, the symposium will also include presentations that highlight disease agnostic approaches that are relevant across individual gastrointestinal disciplines, such as evidence-based recommendations on the use of biomarkers.Click on the link to register for this symposium https://www.onconxt.com/igics/registrationRegistered participants are encouraged to send us questions & problem statements that can be discussed during this symposium.Your active participation will make our e�orts meaningful and conclusive. Regards,

Dr. Tejinder SinghFounder & EC Member - OncoNXTSr. Consultant Medical OncologistApollo HospitalNavi Mumbai

Dr. Adwaita GoreFounder & EC Member - OncoNXTSr. Consultant Medical OncologistPrince Aly Khan Hospital & Zen Multi Speciality HospitalMumbai

Welcome Address


Dear Colleagues,The Indian Gastrointestinal Cancers Symposium 2020 was conceived with an idea to form our national review meet to discuss noteworthy publications and practice-changing trends. Hence the theme of this academia is “Understanding, Integrating & Accelerating Personalized Care” for patients across multiple types of gastrointestinal cancers. This meeting will be held in two batches on 7th and 8th August and 28th and 29th August as an educational virtual series.This symposium will be an annual feature amongst multiple educational programs organised by OncoNXT – a collaborative educational initiative for oncology and haematology.The primary goal of this meeting is to guide practising oncologist on integrating the best and most current evidence into their day-to-day routine care for patients with GI cancers. This symposium series will also bring a practical perspective on how to optimize multidisciplinary care for some of the more complex clinical management decisions. Presenters from across India will be invited, and International Speakers will discuss how biomarker testing, age, and other patients and disease-related factors can influence appropriate diagnostic and treatment approaches.Presentations, debates, a case-based grand round will be organized around specific disease states, including oesophagal and gastric cancers; pancreatic and hepatobiliary cancers; and colorectal and anal cancers. However, the symposium will also include presentations that highlight disease agnostic approaches that are relevant across individual gastrointestinal disciplines, such as evidence-based recommendations on the use of biomarkers.Click on the link to register for this symposium https://www.onconxt.com/igics/registrationRegistered participants are encouraged to send us questions & problem statements that can be discussed during this symposium.Your active participation will make our e�orts meaningful and conclusive. Regards,

INDIAN GASTROINTESTINALCANCERS SYMPOSIUM 2020

Scientific Committee Members

Target Audience

• Medical Oncologist

• Surgical Oncologist

• Radiation Oncologist

• Interventional Radiologist

• Molecular Oncologist

This Symposium is designed for medical, radiation and surgical oncologists; gastroenterology surgeons, gastroenterologists and hepatologists involved in cancer care; and interventional radiologists. Other healthcare professionals involved in the care of patients diagnosed with GI malignancies may benefit from this program.

Learning Objectives

Upon conclusion of this program, participants should be able to:

» Interpret the most up-to-date and practice-relevant data published in 2019 and 2020.

» Integrate evidence-based interdisciplinary treatment strategies into clinical practice.

» Determine the usefulness of genomic and immune-based treatment approaches in oncology.

» Review the current and future role of immunotherapy strategies in various GI malignancies.

» Select the appropriate treatment strategy for patients with early stage cancers of GE junction, rectum, pancreas, and liver.

» Understand the molecular biology and genetics of colorectal & other GI cancers.

» Learn the appropriate regimens for sequencing therapies across multiple GI malignancies.

7TH-8TH & 28TH-29TH AUGUST, 2020

Day 3 | Friday, 28th August, 2020Scientific Program


Hepatobiliary Carcinoma7:00pm - 7:05pm Opening Remarks7:05pm - 8:00pm Session 7 : Recent Advances Chairpersons : Jagdishwar Goud

Surgical Oncologist, Hyderabad Vimal Someshwar

Interventional Radiologist, Mumbai7.05pm - 7.25pm Locoregional Treatment in HCC Speaker : Sanjay Baijal

Interventional Radiologist, Delhi7.25pm - 7.45pm Novel and targeted therapy in biliary cancers Speaker : T. Raja

Medical Oncologist, Chennai8:00pm - 8:30pm Session 8 : Debate Optimal first -Line Therapy for HCC is VEGF

Targeted Therapy or A Checkpoint Inhibitor? Moderator : Chetan Deshmukh

Medical Oncologist, Pune » For - Anti VEGF TKI therapy Speaker : Muzammil Shaikh

Medical Oncologist, Mumbai » For - CKI therapy Speaker : Amit Rauthan

Medical Oncologist, Bangalore



Day 3 | Friday, 28th August, 2020Scientific Program

Hepatobiliary Carcinoma8:10pm - 9:00pm Session 9 : Grand Rounds in HCC Chairpersons : Shishir Shetty

Surgical Oncologist, Mumbai S K Shrivastava

Radiation Oncologist, Mumbai Moderator : M Vamshi Krishna

Medical Oncologist, Hyderabad Panelists : Krishna Prasad

Medical Oncologist, Mangalore Padmaj Kulkarni

Medical Oncologist, Pune Nilesh Lokeshwar

Medical Oncologist, Mumbai Anant Ramaswamy

Medical Oncologist, Mumbai Ajit K Yadav

Interventional Radiologist, Delhi Ganesh Nagrajan

Gastroenterology Surgeon, Mumbai Rajiv Lochan

HPB Transplant Surgeon, Bangalore Vinayak Makka

Medical Oncologist, Bangalore 9:00pm - 9:05pm Concluding Remarks



Scientific Program

Pancreatic Carcinoma7:05pm - 8:00pm Session 10 : Recent Advances Chairpersons : Shivendra Singh

HPB surgeon, Delhi P Vijay Anand Reddy

Radiation Oncologist, Hyderabad7.05pm - 7.25pm Actual algorithm in advanced metastatic

adenocarcinoma pancreas Speaker : Senthil Rajappa

Medical Oncologist, Hyderabad7.25pm – 7.45pm Can we maximize management of Locally advanced

pancreatic adenocarcinoma Speaker : Govind Babu

Medical Oncologist, Bangalore8:00pm - 8:30pm Session 11 : Debate Optimal Treatment for Resectable Pancreatic

Cancer Moderator : Ashish Bakshi

Medical Oncologist, Mumbai » For - Total Neoadjuvant therapy Speaker : L K Rajeev

Medical Oncologist, Bangalore » For - Adjuvant therapy Speaker : Salil Patkar

Medical Oncologist, Mumbai

Hepatobiliary Carcinoma8:10pm - 9:00pm Session 9 : Grand Rounds in HCC Chairpersons : Shishir Shetty

Surgical Oncologist, Mumbai S K Shrivastava

Radiation Oncologist, Mumbai Moderator : M Vamshi Krishna

Medical Oncologist, Hyderabad Panelists : Krishna Prasad

Medical Oncologist, Mangalore Padmaj Kulkarni

Medical Oncologist, Pune Nilesh Lokeshwar

Medical Oncologist, Mumbai Anant Ramaswamy

Medical Oncologist, Mumbai Ajit K Yadav

Interventional Radiologist, Delhi Ganesh Nagrajan

Gastroenterology Surgeon, Mumbai Rajiv Lochan

HPB Transplant Surgeon, Bangalore Vinayak Makka

Medical Oncologist, Bangalore 9:00pm - 9:05pm Concluding Remarks

Day 4 | Saturday, 29th August, 2020



Scientific Program

Pancreatic Carcinoma8:30pm - 9:00pm Session 12 : Grand Rounds in Pancreatic

Carcinoma Chairpersons : Ravi Mohan

Medical Oncologist, Vizag Shekhar Salkar

Surgical Oncologist, Goa Moderator : Ranga Rao

Medical Oncologist, Mumbai Panelists : Bharat Bhosale

Medical Oncologist, Mumbai Krishna Rathnam

Medical Oncologist, Chennai Bharat Vaswani

Medical Oncologist, Hyderabad Kaustav Talpatra

Radiation Oncologist, Mumbai Rahul Sheth

Interventional Radiologist, Mumbai Pranav Chadha

Radiation Oncologist, Mumbai O V Sudheer

GI Surgeon, Cochin Gaurav Gupta

Medical Oncologist, Lucknow 9:00pm - 9:05pm Concluding Remarks & Vote of thanks

Pancreatic Carcinoma7:05pm - 8:00pm Session 10 : Recent Advances Chairpersons : Shivendra Singh

HPB surgeon, Delhi P Vijay Anand Reddy

Radiation Oncologist, Hyderabad7.05pm - 7.25pm Actual algorithm in advanced metastatic

adenocarcinoma pancreas Speaker : Senthil Rajappa

Medical Oncologist, Hyderabad7.25pm – 7.45pm Can we maximize management of Locally advanced

pancreatic adenocarcinoma Speaker : Govind Babu

Medical Oncologist, Bangalore8:00pm - 8:30pm Session 11 : Debate Optimal Treatment for Resectable Pancreatic

Cancer Moderator : Ashish Bakshi

Medical Oncologist, Mumbai » For - Total Neoadjuvant therapy Speaker : L K Rajeev

Medical Oncologist, Bangalore » For - Adjuvant therapy Speaker : Salil Patkar

Medical Oncologist, Mumbai

Day 4 | Saturday, 29th August, 2020


INDIAN GASTROINTESTINALCANCERS SYMPOSIUM 2020INDIAN GASTROINTESTINALCANCERS SYMPOSIUM 2020

Organised by

Virtual Meeting Managed by

Yash JainMobile : +91 77189 50974

E-mail : [email protected] ROUTE Creative Group, LLP Unit No. 9, Cama Industrial Premises Co-Op Society Ltd., Sunmil Compound, Lower Parel

(W), Mumbai - 400 013.


Click on the link for Registeration


onconxt igics 2020 agenda 28 & 29

Documents